Characteristics of antibody responses in west nile virus-seropositive blood donors

Journal of Clinical Microbiology

Volumn 52, Issue 1, 2014, Pages 57-60

  Carson, Paul J ^a,b   Prince, Harry E ^c   Biggerstaff, Brad J ^d   Lanciotti, Robert ^d   Tobler, Leslie H ^e   Busch, Michael ^e  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b SANFORD HEALTH   (United States)

^c Focus Diagnostics   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD DONOR; FEMALE; FLAVIVIRUS INFECTION; HUMAN; IMMUNE FUNCTION TEST; MALE; PRIORITY JOURNAL; REINFECTION; SEROLOGY; VIRAL PLAQUE REDUCTION NEUTRALIZATION TESTING; WEST NILE FLAVIVIRUS;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLOOD DONORS; HUMANS; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; TIME FACTORS; UNITED STATES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84891506495     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01932-13     Document Type: Article

References (19)

1. Petersen LR, Carson PJ, Biggerstaff BJ, Custer B, Borchardt SM, Busch MP. 2012. Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol. Infect. 28:1-5. http://dx.doi.org/10.1017/ S0950268812001070.
2. Carson PJ, Borchardt SM, Custer B, Prince HE, Dunn-Williams J, Winkelman V, Tobler L, Biggerstaff BJ, Lanciotti R, Petersen LR, Busch MP. 2012. Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008. Emerg. Infect. Dis. 18:684-686. http://dx.doi.org/10.3201/eid1804. 111313.
3. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A, Leis AA, Stokic DS, Petersen LR. 2003. Neurologic manifestations and outcome of West Nile virus infection. JAMA 290:511-515. http://dx.doi.org/ 10.1001/jama.290.4.511.
4. De Filette M, Ulbert S, Diamond M, Sanders NN. 2012. Recent progress in West Nile virus diagnosis and vaccination. Vet. Res. 43:16. http://dx.doi.org/ 10.1186/1297-9716-43-16.
5. Nemeth NM, Oesterle PT, Bowen RA. 2009. Humoral immunity to West Nile virus is long-lasting and protective in the house sparrow (Passer domesticus). Am. J. Trop. Med. Hyg. 80:864-869.
6. Diamond MS, Shrestha B, Mehlhop E, Sitati E, Engle M. 2003. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 16:259-278. http://dx.doi.org/10. 1089/088282403322396082.
7. Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, Walsh I, Matud JL, Prince HE, Lanciotti RS, Wright DJ, Linnen JM, Caglioti S. 2008. Virus and antibody dynamics in acute West Nile virus infection. J. Infect. Dis. 198:984-993. http://dx.doi.org/10.1086/591467.
8. Hogrefe WR, Moore R, Lape-Nixon M, Wagner M, Prince HE. 2004. Performance of immunoglobulinG(IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus-and other flavivirus-specific antibodies. J. Clin. Microbiol. 42:4641-4648. http://dx.doi.org/10.1128/JCM.42 .10.4641-4648.2004.
9. Oceguera LF, III, Patiris PJ, Chiles RE, Busch MP, Tobler LH, Hanson CV. 2007. Flavivirus serology by Western blot analysis. Am. J. Trop. Med. Hyg. 77:159-163.
10. Lindsey HS, Calisher CH, Mathews JH. 1976. Serum dilution neutralization test for California group virus identification and serology. J. Clin. Microbiol. 4:503-510.
11. Pierson TC. 2008. Waste not, want not: A viral RNA degradation product modulates West Nile virus pathogenesis. Cell Host Microbe 4:512-513. http://dx.doi.org/10.1016/j.chom.2008.11.004.
12. Diamond MS, Pierson TC, Fremont DH. 2008. The structural immunology of antibody protection against West Nile virus. Immunol. Rev. 225:212-225. http://dx.doi.org/10.1111/j.1600-065X.2008.00676.x.
13. Okuno Y, Fukunaga T, Tadano M, Fukai K, Ikeda T, Sekii K, Ariyoshi H. 1983. Serological studies on volunteers inoculated experimentally with a dengue virus strain in 1943. Biken J. 26:161-163.
14. Imrie A, Meeks J, Gurary A, Sukhbaatar M, Truong TT, Cropp CB, Effler P. 2007. Antibody to dengue 1 detected more than 60 years after infection. Viral Immunol. 20:672-675. http://dx.doi.org/10.1089/vim .2007.0050.
15. Poland JD, Calisher CH, Monath TP, Downs WG, Murphy K. 1981. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull. World Health Organ. 59:895-900.
16. Lai L, Lee TH, Tobler L, Wen L, Shi P, Alexander J, Ewing H, Busch M. 2012. Relative distribution of West Nile virus RNA in blood compartments: Implications for blood donor nucleic acid amplification technology screening. Transfusion 52:447-454. http://dx.doi.org/10.1111/j .1537-2995.2011.03289.x.
17. Appler KK, Brown AN, Stewart BS, Behr MJ, Demarest VL, Wong SJ, Bernard KA. 2010. Persistence of West Nile virus in the central nervous system and periphery of mice. PLoS One 5:e10649. http://dx.doi.org/10.1371/journal.pone. 0010649.
18. Murray K, Walker C, Herrington E, Lewis JA, McCormick J, Beasley DW, Tesh RB, Fisher-Hoch S. 2010. Persistent infection with West Nile virus years after initial infection. J. Infect. Dis. 201:2-4. http://dx.doi.org/10.1086/648731.
19. Gibney KB, Lanciotti RS, Sejvar JJ, Nugent CT, Linnen JM, Delorey MJ, Lehman JA, Boswell EN, Staples JE, Fischer M. 2011. West Nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease. J. Infect. Dis. 203:344-347. http://dx.doi.org/10.1093/infdis/jiq057.